These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6420896)

  • 1. [Effects of slow-acting antirheumatic drugs on blast formation of normal lymphocytes].
    Hamai T; Negishi M; Takahashi T
    Ryumachi; 1983 Aug; 23(4):193-201. PubMed ID: 6420896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of gold compounds on lymphocyte transformation and neutrophil chemotaxis--a comparison between sodium aurothiomalate and auranofin].
    Negishi M; Sato H; Sekine F; Ohno I; Kobayashi K; Ohseto Y; Hamai T; Takahashi T
    Ryumachi; 1983 Jun; 23(3):163-7. PubMed ID: 6414094
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity.
    Walz DT; DiMartino MJ; Griswold DE
    J Rheumatol Suppl; 1979; 5():74-81. PubMed ID: 114651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of natural killer cells in patients with rheumatoid arthritis: I. The effect of drugs used in vivo.
    Russell AS; Miller C
    Clin Exp Rheumatol; 1984; 2(3):227-9. PubMed ID: 6442225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
    Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
    J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes.
    Scheinberg MA; Santos LM; Finkelstein AE
    J Rheumatol; 1982; 9(3):366-9. PubMed ID: 6288942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of auranofin on lymphocyte functions in vitro].
    Strejcek J; Jíra M; Horký J
    Cas Lek Cesk; 1985 Aug; 124(33):1045-7. PubMed ID: 3928163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Generation of human peripheral blood suppressor cell activity by auranofin].
    Kobayashi K; Sato H; Sekine F; Ohno I; Ohseto Y; Hamai T; Negishi M; Takahashi T
    Arerugi; 1982 Sep; 31(9):948-55. PubMed ID: 6217798
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of action of auranofin: effects on humoral immune response.
    Walz DT; Dimartino MJ; Griswold DE
    J Rheumatol Suppl; 1982; 8():32-6. PubMed ID: 6813489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do gold drugs inhibit interleukin-1? Evidence from an in vitro lymphocyte activating factor assay.
    Haynes DR; Garrett IR; Whitehouse MW; Vernon-Roberts B
    J Rheumatol; 1988; 15(5):775-8. PubMed ID: 3139878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anti-inflammatory effect of auranofin].
    Hiroi J; Ohara K; Fujitsu T; Hirai O; Satoh S; Ochi T; Senoh H; Mori J; Kikuchi H
    Nihon Yakurigaku Zasshi; 1985 Dec; 86(6):441-55. PubMed ID: 3937805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-modifying agents in rheumatoid arthritis.
    Lipsky PE
    Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354
    [No Abstract]   [Full Text] [Related]  

  • 19. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of two gold compounds on human polymorphonuclear leukocyte lysosomal function and phagocytosis.
    Kühn SH; Gemperli MB; De Beer FC
    Inflammation; 1985 Mar; 9(1):39-44. PubMed ID: 3920144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.